770-05-8 Octopamine HCl AKSci J10619
 
 
Loading Please Wait...
  J10619    AKSci Reference Standard
Octopamine HCl
, 99%, powder
 
alpha-(Aminomethyl)-4-hydroxybenzyl alcohol hydrochloride
(±)-1-(4-Hydroxyphenyl)-2-aminoethanol hydrochloride




IDENTITY
CAS Number:770-05-8
MDL Number:MFCD00012881
MF:C8H12ClNO2
MW:189.64
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:99%, powder
Physical Form (at 20°C):Solid
Melting Point:169-171°C
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:H2O: soluble
Form:HCl salt

REVIEW

 Octopamine (beta, 4-dihydroxyphenethylamine) is an endogenous biogenic amine that is closely related to norepinephrine, and has effects on the adrenergic and dopaminergic systems. Octopamine HCl, a racemate, is an alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses.. Under the trade names Epirenor, Norden, and Norfen, octopamine is also used clinically as a sympathomimetic agent. It is also a neurotransmitter in some invertebrates.

REFERENCES
[1]Mannich, C.; Thiele, E. beta-Hydroxy-beta-phenylethylamine and related compounds. Archiv der Pharmazie (Weinheim, Germany) (1915), 253, 181-95.
[2] Corrigan, John R.; Langerman, Marie-Jo; Moore, Maurice L. N-Substituted 1-(p-hydroxyphenyl)-2-aminoethanols. Journal of the American Chemical Society (1945), 67, 1894-6.
[3] Fujiwara, Motohatsu; Hattori, Keisuke; Mizusawa, Hideo; Muryobayashi, Takashi; Kato, Yoshiko Pharmacological action octopamine, with special reference to biochemical conversion to noradrenaline. Japanese Journal of Pharmacology (1968), 18(1), 113-29.
[4] Jagiello-Wójtowicz E. Mechanism of central action of octopamine. Pol J Pharmacol Pharm. 1979 Sep-Oct;31(5):509-16.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H302+H312+H332

Precautionary Statements
P261; P264; P270; P271; P280; P301+P312; P302+P352; P304+P340; P312; P322; P330; P363; P501


Current as of October 2, 2022

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS Request COA

⚠️
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.


CATEGORIES

 APIs and Bioactives > Adrenergic Agonists


PubChem
  @PubMed